TF and cancer: Zhou et al. [118] prepared an Fe-doped hollow mesoporous organosilicon (HMON) transferrin (Tf)-modified and DOX-loaded nanoplatform (denoted as DOX@Fe-HMON-Tf) for MRI-guided enhanced ferroptosis/chemical combination therapy of cancer.